2019
DOI: 10.22494/cot.v7i1.96
|View full text |Cite
|
Sign up to set email alerts
|

Personalized medicine: current status and prospects

Abstract: The article presents modern view at the personalized (precision) medicine and discusses the role of genome, glycobiome, microbiome studies in the selection of individualized treatment. Actual data on the options of target immunotherapy of cancer are presented. Up-to-date feasibility of personalized therapy and perspectives for its development are considered.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 19 publications
(43 reference statements)
0
1
0
Order By: Relevance
“…Antimicrobial peptides have recently gathered significant attention as an emerging source of potential antibiotics, due to the swift emergence of multidrug-resistant bacteria and a dwindling antibiotic pipeline [35]. Since the vast majority of antimicrobial peptides are long, comprised of more than 10 amino acids, resulting in significant production costs for their synthesis while simultaneously displaying metabolic instability and relatively poor pharmacological profiles, efforts have been shifted to shorter molecules and the development of new peptidomimetic approaches [35].…”
Section: Application Of Short Peptide Sequences In Medicinementioning
confidence: 99%
“…Antimicrobial peptides have recently gathered significant attention as an emerging source of potential antibiotics, due to the swift emergence of multidrug-resistant bacteria and a dwindling antibiotic pipeline [35]. Since the vast majority of antimicrobial peptides are long, comprised of more than 10 amino acids, resulting in significant production costs for their synthesis while simultaneously displaying metabolic instability and relatively poor pharmacological profiles, efforts have been shifted to shorter molecules and the development of new peptidomimetic approaches [35].…”
Section: Application Of Short Peptide Sequences In Medicinementioning
confidence: 99%